The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study

EuroIntervention 2010;6:562-567.

1. Clinique Pasteur, Toulouse, France; 2. Cardiovascular Center, Aalst, Belgium; 3. Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands; 4. Krankenhaus Sankt Georg, Hamburg, Germany; 5. Mercy Hospital, Auckland, New Zealand; 6. Universitätsklinikum, Ha

Aims: We report here the final 5-year follow-up results from the ENDEAVOR II trial, which was the first randomised trial evaluating the Endeavor™ zotarolimus-eluting stent (ZES) compared wi

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Impact of treatment choice on the outcome of patients proposed for transcatheter aortic valve implantation